• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Contribution of Japan to develop new anticancer agents].

作者信息

Sajjo N

机构信息

Pharmacology Division, National Cancer Center Research Institute, Japan.

出版信息

Gan To Kagaku Ryoho. 1996 Jan;23(2):242-6.

PMID:8611054
Abstract

Many drugs developed in Japan have been started their clinical trials in USA and European countries. The clinical trials in Japan will be requested the strict standard in accordance with the introduction of ICH-GCP. It is strongly requested for the medical student to be educated on the importance and methodology of clinical trials at university.

摘要

相似文献

1
[Contribution of Japan to develop new anticancer agents].
Gan To Kagaku Ryoho. 1996 Jan;23(2):242-6.
2
[Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].新修订的《药物临床试验质量管理规范》下抗癌药物的研发——从药物研发公司开发者的角度来看
Gan To Kagaku Ryoho. 1998 Apr;25(5):663-70.
3
[The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].[日本抗癌药物临床评价方法指南的修订]
Gan To Kagaku Ryoho. 2006 Jul;33(7):1015-9.
4
[Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].[我们在抗癌药物研发中与国际人用药品注册技术协调会（ICH）相关的政策及未来任务——从企业视角的探讨]
Gan To Kagaku Ryoho. 1997 Jan;24(2):229-37.
5
New anticancer drugs under clinical trials in Japan.日本正在进行临床试验的新型抗癌药物。
Hematol Oncol Clin North Am. 1994 Apr;8(2):277-87.
6
[Development of an anticancer drug in Japan based on a new clinical trial system].[基于新临床试验系统的日本抗癌药物研发]
Gan To Kagaku Ryoho. 1998 Feb;25(3):287-94.
7
[Current problems of early phase clinical trials for new anticancer agents in Japan].
Gan To Kagaku Ryoho. 2000 Jun;27(6):925-9.
8
[The guideline for clinical trials proposed by Japan Society for Cancer Therapy (JSCT)].
Gan To Kagaku Ryoho. 1996 Jan;23(2):156-65.
9
[Introduction of anticancer agents to phase I clinical trials].[抗癌药物引入I期临床试验]
Gan To Kagaku Ryoho. 1997 Jan;24(2):246-55.
10
Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.开展抗癌药物的 I 期临床试验：来自欧盟和日本的观点。
Clin Cancer Res. 2010 Mar 15;16(6):1737-44. doi: 10.1158/1078-0432.CCR-09-2228. Epub 2010 Mar 9.